Evolution of Genomic Instability in Diethylnitrosamine-Induced Hepatocarcinogenesis in Mice

被引:47
作者
Aleksic, Kristina [1 ]
Lackner, Carolin [2 ]
Geigl, Jochen B. [1 ]
Schwarz, Martina [3 ]
Auer, Martina [1 ]
Ulz, Peter [1 ]
Fischer, Maria [4 ]
Trajanoski, Zlatko [4 ]
Otte, Marcus [3 ]
Speicher, Michael R. [1 ]
机构
[1] Med Univ Graz, Inst Human Genet, A-8010 Graz, Austria
[2] Med Univ Graz, Inst Pathol, A-8010 Graz, Austria
[3] Forsch U Entwicklungs GmbH, Oridis Biomed, Graz, Austria
[4] Innsbruck Med Univ, Bioctr, Div Bioinformat, Innsbruck, Austria
关键词
PROMOTES CHEMICAL HEPATOCARCINOGENESIS; SMALL HETERODIMER PARTNER; FARNESOID-X RECEPTOR; HEPATOCELLULAR-CARCINOMA; BETA-CATENIN; LIVER-CANCER; DYSPLASTIC NODULES; TRANSGENIC MICE; TUMOR PROMOTION; MOUSE MODELS;
D O I
10.1002/hep.24133
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Diethylnitrosamine (DEN) is a hepatic procarcinogen which is frequently used as an inducer of hepatocellular carcinoma (HCC) in mice. Although mice after DEN exposure are among the most widely used models for liver tumorigenesis, a detailed, mechanistic characterization of the longitudinal changes in the respective tumor genomes has never been performed. Here we established the chronological order of genetic alterations during DEN carcinogenesis by examining mice at different points in time. Tumor samples were isolated by laser microdissection and subjected to array-comparative genomic hybridization (array-CGH) and sequencing analysis. Chromosomal gains and losses were observed in tumors by week 32 and increased significantly by week 56. Loss of distal chromosome 4q, including the tumor suppressors Runx3 and Nr0b2/Shp, was a frequent early event and persisted during all tumor stages. Surprisingly, sequencing revealed that beta-catenin mutations occurred late and were clearly preceded by chromosomal instability. Thus, contrary to common belief, beta-catenin mutations and activation of the Wnt/beta-catenin pathway are not involved in tumor initiation in this model of chemical hepatocarcinogenesis. Conclusion: Our study suggests that the majority of the current knowledge about genomic changes in HCC is based on advanced tumor lesions and that systematic analyses of the chronologic order including early lesions may reveal new, unexpected findings. (HEPATOLOGY 2011;53:895-904)
引用
收藏
页码:895 / 904
页数:10
相关论文
共 46 条
  • [1] Selective pressure during tumor promotion by phenobarbital leads to clonal outgrowth of β-catenin-mutated mouse liver tumors
    Aydinlik, H
    Nguyen, TD
    Moennikes, O
    Buchmann, A
    Schwarz, M
    [J]. ONCOGENE, 2001, 20 (53) : 7812 - 7816
  • [2] p53 deletion impairs clearance of chromosomal-instable stem cells in aging telomere-dysfunctional mice
    Begus-Nahrmann, Yvonne
    Lechel, Andre
    Obenauf, Anna C.
    Nalapareddy, Kodandaramireddy
    Peit, Elvira
    Hoffmann, Eva
    Schlaudraff, Falk
    Liss, Birgit
    Schirmacher, Peter
    Kestler, Hans
    Danenberg, Esther
    Barker, Nick
    Clevers, Hans
    Speicher, Michael R.
    Rudolph, K. Lenhard
    [J]. NATURE GENETICS, 2009, 41 (10) : 1138 - U125
  • [3] Assessing the significance of chromosomal aberrations in cancer: Methodology and application to glioma
    Beroukhim, Rameen
    Getz, Gad
    Nghiemphu, Leia
    Barretina, Jordi
    Hsueh, Teli
    Linhart, David
    Vivanco, Igor
    Lee, Jeffrey C.
    Huang, Julie H.
    Alexander, Sethu
    Du, Jinyan
    Kau, Tweeny
    Thomas, Roman K.
    Shah, Kinial
    Soto, Horacio
    Perner, Sven
    Prensner, John
    Debiasi, Ralph M.
    Demichelis, Francesca
    Hatton, Charlie
    Rubin, Mark A.
    Garraway, Levi A.
    Nelson, Stan F.
    Liau, Linda
    Mischel, Paul S.
    Cloughesy, Tim F.
    Meyerson, Matthew
    Golub, Todd A.
    Lander, Eric S.
    Mellinghoff, Ingo K.
    Sellers, William R.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (50) : 20007 - 20012
  • [4] Primary liver cancer:: Worldwide incidence and trends
    Bosch, FX
    Ribes, J
    Díaz, M
    Cléries, R
    [J]. GASTROENTEROLOGY, 2004, 127 (05) : S5 - S16
  • [5] Demonstration of direct lineage between hepatocytes and hepatocellular carcinoma in diethylnitrosamine-treated rats
    Bralet, MP
    Pichard, V
    Ferry, N
    [J]. HEPATOLOGY, 2002, 36 (03) : 623 - 630
  • [6] Two Decades of Advances in Hepatocellular Carcinoma Research FOREWORD
    Bruix, Jordi
    Llovet, Josep M.
    [J]. SEMINARS IN LIVER DISEASE, 2010, 30 (01) : 1 - 2
  • [7] Disruption of β-catenin pathway or genomic instability define two distinct categories of liver cancer in transgenic mice
    Calvisi, DF
    Factor, VM
    Ladu, S
    Conner, EA
    Thorgeirsson, SS
    [J]. GASTROENTEROLOGY, 2004, 126 (05) : 1374 - 1386
  • [8] RUNX3 is multifunctional in carcinogenesis of multiple solid tumors
    Chuang, L. S. H.
    Ito, Y.
    [J]. ONCOGENE, 2010, 29 (18) : 2605 - 2615
  • [9] FARBER J L, 1984, Pharmacological Reviews, V36, p71S
  • [10] Hepatocellular carcinoma in cirrhosis: Incidence and risk factors
    Fattovich, G
    Stroffolini, T
    Zagni, I
    Donato, F
    [J]. GASTROENTEROLOGY, 2004, 127 (05) : S35 - S50